Search Results

The Isis System is intended for cryogenic destruction of tissue during surgical procedures. The Isis System is indicated for use as a cryosurgical tool in the fields of general surgery, dermatology, neurology (including cryoanalgesia), thoracic surgery, ENT, gynecology, oncology, proctology, and urology. The system is designed to destroy tissue by the application of extreme cold temperatures including prostate and kidney tissue, liver metastases, tumors, skin lesions, and warts.

The Isis System has the following specific indications:

• Urology (ablation of prostate tissue in cases of prostate cancer and Benign Prostate Hyperplasia "BPH")
• Oncology (ablation of cancerous or malignant tissue and benign tumors, and palliative intervention)
• Dermatology (ablation or freezing of skin cancers and other cutaneous disorders. Destruction of warts or lesions, angiomas, sebaceous hyperplasia, basal cell tumors of the eyelid or canthus area, ulcerated basal cell tumors, dermatofibromas small hemanglomas, mucocele cysts, multiple warts, plantar warts, actinic and seborrheic keratoses, cavernous hemanglomas, perianal condylomata, and palliation of tumors of the skin.)
• Gynecology (ablation of malignant neoplasia or benign dysplasia of the female genitalia)
• General surgery (palliation of tumors of the rectum, hemorrhoids, anal fissures, pilonidal cysts, and recurrent cancerous lesions, ablation of breast fibroadenoma)
• ENT (Palliation of tumors of the oral cavity and ablation of leukoplakia of the mouth)
• Thoracic surgery (ablation of arrhythmic cardiac tissue cancerous lesions)
• Proctology (ablation of benign or malignant growths of the anus or rectum, and hemorrhoids)

Cryosurgical unit with argon-cooled probes

The provided text is a 510(k) summary for the Galil Medical Ltd. Isis™ System, a cryosurgical unit. It primarily focuses on the device's classification, predicate devices, and indications for use.

Crucially, this document does not contain information regarding:

• Acceptance criteria for device performance.
• Studies proving the device meets acceptance criteria.
• Device performance results.
• Sample sizes for test or training sets.
• Data provenance.
• Number or qualifications of experts for ground truth.
• Adjudication methods.
• MRMC comparative effectiveness studies.
• Standalone performance studies.
• Type of ground truth used.
• How ground truth was established.

The document is a regulatory approval summary, confirming the device's substantial equivalence to predicate devices for marketing purposes. It does not delve into the detailed technical performance or validation studies typically required for the information requested.

Therefore, I cannot provide the requested table and study details based on the provided input.

Ask a specific question about this device